Towards Healthcare
HPMC Capsules Market Size Drive USD 1.25 Billion by 2034

HPMC Capsules Market Overview 2025 Size, Growth Projections, and Top Companies to Watch

Projections indicate that, the global HPMC capsules market will increase from USD 0.5 billion in 2024 to USD 1.25 billion by 2034, experiencing a CAGR of 9.44% over the next 10 years.The market is growing due to rising demand for plant-based, gelatin-free alternatives. Increasing use in pharmaceuticals and nutraceuticals for moisture-sensitive and clear-label products also supports market expansion.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The HPMC capsules market is projected to reach USD 1.25 billion by 2034, growing at a CAGR of 9.44% from 2024 to 2034.

The HPMC capsules market includes eight segments by capsule type, by functionality release profile, by application, by distribution channel, by capsule size, by sealing type, by end user, and by region.

Key trends include the growth due to the rising demand for plant-based, gelatin-free alternatives.

They are widely used in pharmaceuticals, nutraceuticals, and dietary supplements, especially for products that require clean-label, allergen-free, or plant-based solutions.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions